Suppliers and packages for generic ingredient: pralsetinib
✉ Email this page to a colleague
pralsetinib
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Genentech, Inc. | 50242-210-12 | 1 BOTTLE in 1 CARTON (50242-210-12) / 120 CAPSULE in 1 BOTTLE | 2021-07-01 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Genentech, Inc. | 50242-210-60 | 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE | 2021-07-01 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Genentech, Inc. | 50242-210-83 | 1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE | 2021-07-01 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Genentech, Inc. | 50242-210-90 | 1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE | 2021-07-01 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Rigel Pharmaceuticals, Inc. | 71332-006-12 | 120 CAPSULE in 1 BOTTLE (71332-006-12) | 2024-06-24 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Rigel Pharmaceuticals, Inc. | 71332-006-60 | 60 CAPSULE in 1 BOTTLE (71332-006-60) | 2024-06-24 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Rigel Pharmaceuticals, Inc. | 71332-006-90 | 90 CAPSULE in 1 BOTTLE (71332-006-90) | 2024-06-24 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
